Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 28, 2000

View Archived Issues

NCI awards grant to conduct genetic studies of colon cancer

Milestone reached in MorphoSys and GPC Biotech immunology therapeutics program

MVA vaccine approved for U.K. trials; Kenyan trials expected to follow

Immunomedics commences phase III clinical trial with LymphoCide

Simdax approved in Sweden for severe heart failure

Sangamo and Rosetta to study new therapeutic agents

Trial of novel restenosis treatment AGI-1067 set to begin

NDA submitted for combined niacin/lovastatin cholesterol product

Submission of NDA for lupus therapy completed by Genelabs

CP-654743: a semisynthetic fluorinated ketolide derivative with potential in respiratory infections

DHA shows potent, dose-dependent neuroprotection in animal model of stroke

Topical formulation of Targretin launched in U.S. for CTCL therapy

Welfide pursues a novel therapeutic approach to psychotic symptoms

Abgenix to acquire ImmGenics

Asta Medica presents synthesis and characterization of AWD-34-022, a new anticonvulsant

Ferrer selects new development candidate for the treatment of hypertension

Ilex Oncology's first angiogenesis inhibitor enters phase I in France

Preliminary profile of Esteve's E-6006 indicates potential as antidepressant

Encouraging antitumor activity reported for IGT Pharma's AVLB

Series of cdk inhibitors described in Pharmacia patent

Tissue-selective estrogens patented by Schering

Potential antimigraine agents discovered at Lilly

Novel class of sulfonamides synthesized at Vertex act as inhibitors of HIV protease

Stable and safe antineoplastic agents developed at Ohio State University

Novel cathepsin K inhibitors reportedly useful for osteoporosis

AstraZeneca's new cysteine protease inhibitors claimed for COPD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...